Randomised comparison of inpatient pain management in isolated patellofemoral replacement - pilot study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00029341

Enrollment

Registered

2022-07-05

Start date

2021-09-24

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M17.1

Interventions

Group 1: LIA injection: Preoperatively, a baseline score for the functionality of the knee joint to be operated on is recorded by means of WOMAC, OKS, KOOS (including KOOS-PF) and Kujala score and the

Eligibility

Sex/Gender

All

Age

18 Years to 85 Years

Inclusion criteria

Inclusion criteria: - Indication for primary patellofemoral replacement - Age: 18 - 85 years

Exclusion criteria

Exclusion criteria: - Known diseases of the cardiovascular system that lead to severe limitations in exercise capacity, corresponding to NYHA3 and NYHA4. - Known dementia - Known drug abuse - Intolerances and/or allergies that make participation in the study impossible.

Design outcomes

Primary

Measure	Time frame
Recording of knee joint function using torque measurement 6 weeks postoperatively to record quadriceps femoris muscle function of the 2 study groups with different analgesia regimens (LIA group, NKF group).	—

Secondary

Measure	Time frame
- Analgesic/opioid consumption - Side effects of analgesics - Complications - Patient satisfaction - Length of hospital stay - Assessment of chronic pain status	—

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift, Leitung Klinisches Studienmanagement

yvonne.noll@diakovere.de0511-5354-649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026